In Reply We thank Bullimore and Berntsen for their letter. In response to their point on the 2 studies1,2 investigating low-dose (0.01%) atropine, we reply that we used the data of the first study to compare between the group receiving atropine and the control group. However, we presented data from both studies for comparisons of different concentrations of atropine in the Supplement accompanying our report (eFigure 2).
Gong Q, Janowski M, Liu L. Low-Dose Atropine for Myopia Control—Reply. JAMA Ophthalmol. 2018;136(3):303–304. doi:10.1001/jamaophthalmol.2017.6641
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: